7.89

4.50% 0.34

Portage Biotech Inc (PRTG)

Overview News Price History Option Chain Why PRTG Down? Discussions Forecast Stock Split

Portage Biotech Inc stock is traded at $7.89, with a volume of 20,925. It is up +4.50% in the last 24 hours and up +16.89% over the past month. Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

Previous Close:

$7.55

Open:

$7.4

24h Volume:

20,925

Relative Volume:

0.02

Market Cap:

$8.84M

Revenue:

Net Income/Loss:

$-67.28M

P/E Ratio:

-0.0834

EPS:

-94.66

Net Cash Flow:

$-9.80M

1W Performance:

-3.55%

1M Performance:

+16.89%

6M Performance:

+92.91%

1Y Performance:

+47.75%

1-Day Range:

$7.40

$8.15

1-Week Range:

$7.40

$8.25

52-Week Range:

$2.098

$23.01

Portage Biotech Inc Stock (PRTG) Company Profile

Name

Portage Biotech Inc

Sector

Healthcare (1170)

Industry

Biotechnology (671)

Phone

Address

Employee

Twitter

Next Earnings Date

2024-12-26

Latest SEC Filings

PRTG's Discussions on Twitter

Compare PRTG with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRTG Portage Biotech Inc	7.89	13.46M	0	-67.28M	-9.80M	-94.66
ONC Beigene Ltd Adr	228.38	25.07B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	438.65	109.14B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.27	36.39M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	594.32	56.98B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	71.31	5.39B	0	-153.72M	-103.81M	-2.00

Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-18-22	Resumed	Oppenheimer	Outperform
Mar-07-22	Initiated	H.C. Wainwright	Buy
Sep-21-21	Initiated	Oppenheimer	Outperform
Sep-02-21	Initiated	B. Riley Securities	Buy
Aug-19-21	Initiated	Cantor Fitzgerald	Overweight

Portage Biotech Inc Stock (PRTG) Latest News

Apr 30, 2025

Portage Biotech Stock Surges On New Preclinical Data In Mesothelioma Trial: Retail Gets More Bullish - Asianet Newsable

Apr 30, 2025

Apr 29, 2025

Investing in Portage Biotech Inc (PRTG) Is Getting More Attractive - knoxdaily.com

Apr 29, 2025

Market Analysts see Portage Biotech Inc [PRTG] gaining to $26. Time to buy? - dbtnews.com

Apr 29, 2025

Portage Biotech (PRTG) Reports Promising Preclinical Results for PORT-7 | PRTG Stock News - GuruFocus

Apr 29, 2025

Insider Activity Signals Optimism for Portage Biotech (PRTG) - GuruFocus

Apr 29, 2025

Portage Biotech Stock Surges On New Preclinical Data In Mesothelioma Trial: Retail Gets More Bullish By Stocktwits - Investing.com India

Apr 29, 2025

Apr 28, 2025

Portage Biotech Reports Confirmatory Preclinical Results in Meso - GuruFocus

Apr 28, 2025

The Future of Portage Biotech Inc: Analyzing PRTG - investchronicle.com

Apr 28, 2025

How analysts predict Portage Biotech Inc (PRTG) will perform this quarter? - uspostnews.com

Apr 28, 2025

Portage Biotech Stock Surges As It Prepares For Human Trial - Benzinga

Apr 28, 2025

Portage Biotech stock soars on promising preclinical results By Investing.com - Investing.com Nigeria

Apr 28, 2025

Portage Biotech stock soars on promising preclinical results - Investing.com Australia

Apr 28, 2025

Portage Biotech’s PORT-7 shows efficacy in mesothelioma preclinical study - TipRanks

Apr 28, 2025

Top Premarket Gainers - marketscreener.com

Apr 28, 2025

Portage Biotech Announces Preclinical Success for PORT-7 in Mesothelioma - TipRanks

Apr 28, 2025

Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7 - The Manila Times

Apr 28, 2025

New Cancer Breakthrough: PORT-7 Outperforms Standard Treatment in Mesothelioma Study - Stock Titan

Apr 28, 2025

Apr 26, 2025

Insider Stock Buying Reaches US$2.15m On Portage Biotech - Yahoo

Apr 26, 2025

Apr 23, 2025